Sandrine Hiret

3PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Apr 10, 2022
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.

Benoit Rousseau, Ivan Bieche, Eric Pasmant

|May 30, 2018
Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors.

Sandrine Hiret, Nicolas Isambert, Carlos Gomez-Roca

Pageof 1

Frequent Collaborators

2 joint publications

Antoine Hollebecque

2 joint publications

David Malka

1 joint publications

Benoit Rousseau

1 joint publications

Ivan Bieche